Navigation Links
DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC

supply the vaccine for both civilian and military use."

The Company recently announced the publication of key results with BT-VACC™ showing that mucosal immunization with a multivalent version of the vaccine induces a robust immune response that resulted in protection against several of the natural serotypes of botulinum toxin. BT-VACC™ is composed of a component of what is known as the heavy chain of each of the A, B, and E serotypes of botulinum toxin. The heavy chain component lacks the region of the toxin that is responsible for blocking neurotransmitter functions. The subunits can bind avidly to receptors on the surface of mucosal cells and traverse lung and gastrointestinal tissue to stimulate immunity. Because the binding subunits do not contain the toxic part of the molecule, the vaccine is safe and stimulates antibodies in not only the blood but those antibodies that coat mucosal surfaces. It is thought that antibodies that are present in lung and gastrointestinal secretions will block the uptake of the toxin before entering the bloodstream and reaching peripheral nerves.

About Botulinum Toxin

Botulinum toxin is an extremely potent neurotoxin of bacterial origin that inhibits peripheral nerve function, causing severe and often fatal descending flaccid muscle paralysis. Natural botulism resulting from ingestion of toxin from contaminated food is very rare, but artificially, botulism also can result from bioterrorism and biowarfare. Because extremely small amounts of the toxin can cause neurological effects, it is classified as a category A Biothreat by the CDC. The toxin can enter the body very efficiently through lung tissue and through the gastrointestinal tract, making the threat of purposeful food contamination with botulinum toxin a real possibility as a biological weapon. Because the toxin rapidly enters target neural cells, exposure is difficult to treat with any available therapeutic regimen other than supportive care
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
2. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
3. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
4. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis

Post Your Comments:
(Date:11/23/2009)...RINCETON,N.J.,Nov.23/PRNewswire-FirstCall/--Pharma...lmentofCohort2,ledbyitspartnerRoche(SWX:ROG.VX;RO....ype1and4patientsintheongoingphase2btrialofRG7128,a...orthetreatmentofchronichepatitisCvirus(HCV)infecti...ndependentDataMonitoringCommittee(DMC)ofallavailab...
(Date:11/23/2009)...OVATO,Calif.,Nov.23/PRNewswire-FirstCall/--RaptorP... RPTP ),todayannouncedresultsfromaPhase2bclinicalt...trate("DRCysteamine")inpatientswithnephropathiccys...rsityofCalifornia,SanDiego("UCSD")GeneralClinicalR...okineticsandpharmacodynamicsofasingledoseofDRCyste...
(Date:11/23/2009)...LISOVIEJO,Calif.,Nov.23/PRNewswire-FirstCall/--Oce...als International(NYSE: VRX ),todayannouncedthatit...iniumbromide,anauthorizedgeneric(AG)versionofLibra...tstobeasignificantplayerintheLibrax®genericma...rtantdivisionofourU.S.businesswithitssuccessfullau...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Oceanside Pharmaceuticals Announces Launch of Librax(R) AG 2U S Faces Shortage of Heart Surgeons 56866 1U S Faces Shortage of Heart Surgeons 56866 2U S Faces Shortage of Heart Surgeons 56866 3Physicians Coalition for Injectable Safety Urges Reporting of Suspected Illegal Solicitation or Use of Botox Restylane Radiesse and Others 56864 1Physicians Coalition for Injectable Safety Urges Reporting of Suspected Illegal Solicitation or Use of Botox Restylane Radiesse and Others 56864 2Physicians Coalition for Injectable Safety Urges Reporting of Suspected Illegal Solicitation or Use of Botox Restylane Radiesse and Others 56864 3CBS Radio Presents Cars for Courage Boat Drive Sept 13 56861 1CBS Radio Presents Cars for Courage Boat Drive Sept 13 56861 2
(Date:11/23/2009)...a simple case for a New York auto accident attorne... , New York (PRWEB) Novemb...w York auto accident attorneys passed to criminal...ed fatal., , , , ,According to the New York Dail...d killed during a heated road-rage argument. Accor...
(Date:11/23/2009)...lationHealthPrograms ,, LOVELAND,Ohio,Nov.23/P...stitute(PHII),anon-profit501(c)(3)organization,isp...ovedtheHealthcareTransparencyAccreditationProgram,...M),alife,health,andwellnesscompanybasedinFarmingto...tationsealforfiveofitsprograms. ,, ThomasW.Wils...
(Date:11/23/2009)...vingweekendmarksthe36thannualStateFarmBayouClassic...esportsmanshipandprideoftwoschoolsbutitissomuchmor...ce. ,, ForthecrewofthenewU.S.CoastGuardship,the...rktotestandlaunchabrandnewshiptoprotectourshores. ...deBovellandtherestofthecrewwillbegintestingtheship...
(Date:11/23/2009)...bly captured the attention of public health offici...s from Children,s Hospital Boston, based on patien...veral recent flu seasons, shows that another virus...stantially greater disease toll among young childr...ome from the pre-H1N1 influenza era, the analysis,...
(Date:11/23/2009)...t outcomes, research suggests , , MONDAY...ug therapy shows promise in treating patients with..., The study from the Massachusetts General Hosp...nd tumor response in patients treated with bevaciz... helped slow the growth of other cancers, in addit...
Breaking Medicine News(10 mins):Health News:An Incident of Road Rage Turns Into Murder 2Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 2Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 3Health News:Nothing Is Like Being There 2Health News:Amid the flu epidemic, don't forget RSV in young children 2Health News:Amid the flu epidemic, don't forget RSV in young children 3Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2
...ole is counteracting Canada,s ban on direct-to-con...o more than $90 million worth of ads, including th...ng to a study by UBC researchers. , Barbara Mintz...m 1995 to 2006 and saw spending rise from less tha...
... www.aftertheinjury.org to Help Parents and Kids...auma season" is the unfortunate nickname for summe...d increased outdoor activity level brings an estim...icle crashes, water-related accidents, pedestrian ...
....J., May 27 Nuvilex, Inc. (OTC Bulletin Board: N...pany, announced today that Infinitink(TM), the wor...h safe and more easily removed, is the subject of ...t and broaden the audience for this already popula...
... 27 Body shaping will be one of the main acts thi...Eleme Medical, a premier body shaping company, wil...duction and body sculpting procedures, SmoothShape...es patient and star of Bravo,s mega-hit reality sh...
...and SAN FRANCISCO, May 27 WeissComm Group tod...ia Group , a social media consulting company foun...s Chief Technology and Media Officer. WeissComm a... continue to operate and grow this function for We...
...earch Group,s new European dental implant report n...efore , , WALTHAM, Mass., May 27 Millennium Rese...tal Implants 2009 report finds that, despite unfa...oth dentist and patient demand. This new report pr...
Other Medicine News:Health News:Legal loophole exposes Canadians to drug advertising banned in US: UBC research 2Health News:Summertime or 'Trauma Season?' - Increase in Outdoor Activities Spurs Higher Risk for Child Injury 2Health News:Summertime or 'Trauma Season?' - Increase in Outdoor Activities Spurs Higher Risk for Child Injury 3Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 2Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 3Health News:Body Shaping Gets the Spotlight with Industry Experts and Celebrity Guest to Showcase SmoothShapes(R) and SmoothLipo(TM) Systems at THE Aesthetic Show in Las Vegas 2Health News:Body Shaping Gets the Spotlight with Industry Experts and Celebrity Guest to Showcase SmoothShapes(R) and SmoothLipo(TM) Systems at THE Aesthetic Show in Las Vegas 3Health News:WeissComm Group Acquires Common Sense Media Group, Appoints Founder Bob Pearson Chief Technology and Media Officer to Help Clients Evaluate and Optimize Social Media 2Health News:WeissComm Group Acquires Common Sense Media Group, Appoints Founder Bob Pearson Chief Technology and Media Officer to Help Clients Evaluate and Optimize Social Media 3Health News:WeissComm Group Acquires Common Sense Media Group, Appoints Founder Bob Pearson Chief Technology and Media Officer to Help Clients Evaluate and Optimize Social Media 4Health News:Increasingly Competitive European Dental Implant Market to Reach Over $2.7 Billion by 2013 Despite Unfavorable Economic Conditions 2Health News:Increasingly Competitive European Dental Implant Market to Reach Over $2.7 Billion by 2013 Despite Unfavorable Economic Conditions 3
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: